Thursday , November 21 2024
Home / Mike Norman Economics / New York coronavirus antibody study: Why I had nothing to say to the press on this one. — Andrew Gelman

New York coronavirus antibody study: Why I had nothing to say to the press on this one. — Andrew Gelman

Summary:
Do I want to be quoted as saying this estimate is pretty good? Or that it’s flawed? I don’t know. There’s no data, no report. Based on the news report, the study seems to have been conducted by the state health department, and that sounds like a good sign. In general I’ll have more trust in a study from the state health department than from some Stanford professors. I’m not joking here: the health department are professionals and they don’t have the same incentives that academics have to hype their research. But, still, I have no idea what’s going on.... Statistical Modeling, Causal Inference, and Social ScienceNew York coronavirus antibody study: Why I had nothing to say to the press on this one.Andrew Gelman | Professor of Statistics and Political Science and Director of the Applied

Topics:
Mike Norman considers the following as important:

This could be interesting, too:

New Economics Foundation writes Building hope

New Economics Foundation writes Are oil and gas workers the coalminers of our generation?

Mike Norman writes Tariffs As A Fiscal Tool? — Brian Romanchuk

John Quiggin writes Trump’s dictatorship is a fait accompli

Do I want to be quoted as saying this estimate is pretty good? Or that it’s flawed? I don’t know. There’s no data, no report. Based on the news report, the study seems to have been conducted by the state health department, and that sounds like a good sign. In general I’ll have more trust in a study from the state health department than from some Stanford professors. I’m not joking here: the health department are professionals and they don’t have the same incentives that academics have to hype their research. But, still, I have no idea what’s going on....
Statistical Modeling, Causal Inference, and Social Science
New York coronavirus antibody study: Why I had nothing to say to the press on this one.
Andrew Gelman | Professor of Statistics and Political Science and Director of the Applied Statistics Center, Columbia University
Mike Norman
Mike Norman is an economist and veteran trader whose career has spanned over 30 years on Wall Street. He is a former member and trader on the CME, NYMEX, COMEX and NYFE and he managed money for one of the largest hedge funds and ran a prop trading desk for Credit Suisse.

Leave a Reply

Your email address will not be published. Required fields are marked *